

Abivax missed EPS estimates but beat sales in H1; shares dipped. Wedbush and Truist cut price targets to $118 and $151.
You can purchase shares of Abivax (NASDAQ:ABVX) through any online brokerage.
Other companies in Abivax’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Abivax has a consensus price target of $119.86.
The stock price for Abivax (NASDAQ: ABVX) is $83.15 last updated November 17, 2026 at 6:21 PM EST.
There are no upcoming dividends for Abivax.
Abivax does not have any upcoming earnings scheduled.
There is no upcoming split for Abivax.
Abivax is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is...